[3S14m] Front line on development of analytical technologies for next-generation therapeutic antibody evaluation that contributes to drive medical innovation

10:20 AM - 10:45 AM JST(1:20 AM - 1:45 AM UTC)

[3S14m-05] Development of rapid formulation optimization method for next generation antibody drugs

^○Susumu Uchiyama (Department of Biotechnology, Graduate School of Engineering, The University of Osaka)

キーテクノロジー：凝集体評価法

Keywords:

抗体医薬品,次世代抗体,凝集,安定性

Password required to view